Mid-Morning Market Update: Markets Open Lower; Avantor To Acquire Masterflex
Following the market opening Tuesday, the Dow traded down 0.59% to 35,159.50 while the NASDAQ fell 0.05% to 15,355.16. The S&P also fell, dropping 0.35% to 4,519.52.
Why Is CorMedix Stock Dropping On Tuesday?
CorMedix Inc (NASDAQ:CRMD) stock is plunging after updating its resubmission timeline for the DefenCath marketing application. CorMedix has encountered delays at…
CorMedix Says Was Informed By Contract Manufacturer That There Are Issues Unrelated To DefenCath Manufacturing Activities; Timeline For Co. and CMO To Address Deficiencies That Are Required For Resubmission Of DefenCath NDA Is Uncertain
CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today provided an update
78 Biggest Movers From Friday
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
Cormedix Q2 EPS $(0.12) Beats $(0.17) Estimate
Cormedix (AMEX:CRMD) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 29.41 percent.
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
74 Biggest Movers From Friday
Gainers
MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter.